188 related articles for article (PubMed ID: 34114552)
21. TSH-STAINING PITUITARY ADENOMAS: RARE, SILENT, AND PLURIHOROMONAL.
Polanco Santos C; Sandouk Z; Yogi-Morren D; Prayson R; Recinos P; Kennedy L; Hamrahian AH; Pantalone KM
Endocr Pract; 2018 Jun; 24(6):580-588. PubMed ID: 29949434
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of pituitary adenomas: a systematic review.
Ezzat S; Asa SL; Couldwell WT; Barr CE; Dodge WE; Vance ML; McCutcheon IE
Cancer; 2004 Aug; 101(3):613-9. PubMed ID: 15274075
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
24. Pathology of invasive pituitary tumors with special reference to functional classification.
Scheithauer BW; Kovacs KT; Laws ER; Randall RV
J Neurosurg; 1986 Dec; 65(6):733-44. PubMed ID: 3095506
[TBL] [Abstract][Full Text] [Related]
25. Pituitary tumours: pituitary incidentalomas.
Molitch ME
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):667-75. PubMed ID: 19945030
[TBL] [Abstract][Full Text] [Related]
26. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
[TBL] [Abstract][Full Text] [Related]
28. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
29. Pituitary incidentalomas: A guide to assessment, treatment and follow-up.
Paschou SA; Vryonidou A; Goulis DG
Maturitas; 2016 Oct; 92():143-149. PubMed ID: 27621252
[TBL] [Abstract][Full Text] [Related]
30. Clinically Nonfunctioning Pituitary Incidentalomas: Characteristics and Natural History.
Tresoldi AS; Carosi G; Betella N; Del Sindaco G; Indirli R; Ferrante E; Sala E; Giavoli C; Morenghi E; Locatelli M; Milani D; Mazziotti G; Spada A; Arosio M; Mantovani G; Lania AGA
Neuroendocrinology; 2020; 110(7-8):595-603. PubMed ID: 31525736
[TBL] [Abstract][Full Text] [Related]
31. [Pituitary gland tumors].
Jesser J; Schlamp K; Bendszus M
Radiologe; 2014 Oct; 54(10):981-8. PubMed ID: 25316104
[TBL] [Abstract][Full Text] [Related]
32. [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors].
Wiesner TD; Trantakis C; Meixensberger J; Koch CA; Zimmer C; Paschke R
Med Klin (Munich); 2005 Apr; 100(4):173-9. PubMed ID: 15834525
[TBL] [Abstract][Full Text] [Related]
33. Pituitary Apoplexy: A Comprehensive Review.
Muthukumar N
Neurol India; 2020; 68(Supplement):S72-S78. PubMed ID: 32611895
[TBL] [Abstract][Full Text] [Related]
34. Pituitary incidentaloma: to operate or not to operate?
Donckier JE; Gustin T
Acta Chir Belg; 2012; 112(4):255-60. PubMed ID: 23008988
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for pituitary adenoma: long-term outcome and sequelae.
McCord MW; Buatti JM; Fennell EM; Mendenhall WM; Marcus RB; Rhoton AL; Grant MB; Friedman WA
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):437-44. PubMed ID: 9308948
[TBL] [Abstract][Full Text] [Related]
36. Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade.
Chinezu R; Fomekong F; Lasolle H; Trouillas J; Vasiljevic A; Raverot G; Jouanneau E
World Neurosurg; 2017 Oct; 106():315-321. PubMed ID: 28676462
[TBL] [Abstract][Full Text] [Related]
37. Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.
Hlaváč M; Knoll A; Mayer B; Braun M; Karpel-Massler G; Etzrodt-Walter G; Coburger J; Wirtz CR; Paľa A
Neurosurg Focus; 2020 Jun; 48(6):E14. PubMed ID: 32480376
[TBL] [Abstract][Full Text] [Related]
38. [Non-functioning pituitary tumors - short presentation of the first German guideline].
Deutschbein T; Jaursch-Hancke C; Fassnacht M
Dtsch Med Wochenschr; 2020 Oct; 145(20):1444-1449. PubMed ID: 33022723
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, Clinical Features, and Natural History of Incidental Clinically Non-Functioning Pituitary Adenomas.
Iglesias P; Arcano K; Triviño V; García-Sancho P; Díez JJ; Villabona C; Cordido F
Horm Metab Res; 2017 Sep; 49(9):654-659. PubMed ID: 28759937
[TBL] [Abstract][Full Text] [Related]
40. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.
Batista D; Courkoutsakis NA; Oldfield EH; Griffin KJ; Keil M; Patronas NJ; Stratakis CA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5134-40. PubMed ID: 15941871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
